Protagenic Therapeutics

/Protagenic Therapeutics

Follow-on

Protagenic Therapeutics

Biopharmaceutical

We are a biopharmaceutical corporation specializing in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders utilizing synthetic forms of endogenous brain signaling peptides that can dampen overactive stress responses.

Symbol

PTIX

Last Closing Price
$5.20

Shares
2,650,000

Anticipated Date
April 27, 2021

Underwriters
Kingswood Capital

This offering is no longer available

To view the prospectus for Protagenic Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange